NCT03227276

Efficacy and Safety of Litramine in 1 Year Weight Loss Study

Double-blind, Randomised, Placebo-controlled 1-year Study to Evaluate the Efficacy and Safety of Litramine in Reducing Body Weight in Overweight and Moderately Obese Subjects

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 166 (actual)
• Sponsor: InQpharm Group · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Accepted

Summary

To evaluate the efficacy of Litramine in reducing body weight in the context of an energy-restricted diet in overweight and moderately obese subjects

Conditions

• Obesity; Excess Calories
• Overweight and Obesity
• Weight Loss

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Litramine	2 tablets to be taken 3 times a day after meals
DIETARY_SUPPLEMENT	Placebo tablet	2 tablets to be taken 3 times a day after meals

Timeline

• Start date: 2017-08-14
• Primary completion: 2020-02-19
• Completion: 2020-02-19
• First posted: 2017-07-24
• Last updated: 2020-02-28

Locations

1 site across 1 country: Germany